Glimepiride Impurity 11 | CAS 4994-13-2 - Request Quote
Glimepiride Impurity 11
| SZ CAT No: | SZ-G008030 |
| CAS No | 4994-13-2 |
| Mol.F. | C7H13NO |
| Mol.Wt. | 127.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 90048-87-6 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Glimepiride Impurity 11 is chemically 4-Methylcyclohexan-1-one oxime. Glimepiride Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Glimepiride Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Glimepiride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 4994-13-2
Purchase 4994-13-2
Order 4994-13-2
Enquire 4994-13-2
price of 4994-13-2
4994-13-2 Supplier
4994-13-2 Manufacturer
4994-13-2 Exporter
buy high quality Glimepiride Impurity 11
Purchase Glimepiride Impurity 11
Glimepiride Impurity 11 suppliers
Glimepiride Impurity 11 manufacturers
Glimepiride Impurity 11 price
Order Glimepiride Impurity 11
Enquire Glimepiride Impurity 11
Glimepiride Impurity 11 cost
Glimepiride Impurity 11 Supplier
Glimepiride Impurity 11 Distributor
Glimepiride Impurity 11 for Method Validation
Glimepiride Reference Standard
Glimepiride Impurity 11 for ANDA Filing
Glimepiride Impurity 11 for Forced Degradation Studies
Glimepiride Impurity 11 Identification Standards
Glimepiride Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.